What’s more, the results of combination therapy showed that compared with PD-1 antibody therapy alone, the expression of PD-L1 and LAG3 in tumor tissues were markedly decreased, and the expression of CTLA-4 was significantly increased. The gene discussed is LAG3; the disease is neoplasm.